Gilead Sciences, the Bay Area biotech giant best known for its popular HIV drugs and COVID-19 treatment Remdesivir, is laying ...
Sciences announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81%, ...
Fintel reports that on November 14, 2024, Citigroup initiated coverage of Gilead Sciences (NasdaqGS:GILD) with a Buy ...
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Gilead’s bread and butter has been ...
Partly cloudy with a high of 68 °F (20 °C). Winds E. Night - Partly cloudy. Winds variable. The overnight low will be 55 °F (12.8 °C). Partly cloudy today with a high of 80 °F (26.7 °C) and ...
Abhishek Bachchan channels a grumpy-cat look in the first look poster of Shoojit Sircar’s I Walk to Talk. The film is the story of a pot-bellied NRI man and his relationship with his daughter.
Lakshmi pujan is also organized, which brings happiness and prosperity in the house. Drawings and posters also have special importance in making the celebration of Diwali more colourful.
Some art museums overawe with the sweep of their collections. Others thrill with a few perfectly placed masterworks. The best of them embody their cities’ ambitions and fulfill an ideal ...
STAT+ subscribers can sign up here to get it delivered to their inbox. The next referendum on Gilead Sciences’ oft-criticized oncology business is approaching. Circle Nov. 5 on your calendars.
Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, is a global biopharmaceutical leader known for its groundbreaking work in antiviral therapies. Valued at a market cap of $ ...
Ahead of Prabhas' birthday, the makers of The Raja Saab, directed by Maruthi, released a stylish new poster showcasing the pan-Indian actor, generating excitement for the film's release on April 10, ...
The treatment combines MSD’s islatravir with Gilead’s lenacapavir. Credit: Ground Picture via Shutterstock. Gilead Sciences and MSD are advancing their once-weekly HIV treatment regimen to Phase II ...